Science & Technology
 
Event Calendar
Targacept’s proprietary discovery platform provides the company with a strong competitive advantage.
We are a leader in the field of neuronal nicotinic receptor (NNR) chemistry and biology. Our product candidates are designed to selectively act on NNRs, an underexploited class of molecular targets, to meet unmet medical needs across a broad spectrum of therapeutic indications with large market potential, including:

  • Alzheimer's disease
  • Cognitive dysfunction in schizophrenia
  • Depression/Anxiety
  • Pain
  • Smoking cessation
  • Obesity
  • Schizophrenia 
  • Addiction
  • Parkinson's disease
  • Inflammation
Focus: NNR
Neuronal nicotinic receptors (NNRs)

Pentad

 

©2008 Targacept, Inc. Terms of Use Home Directions Contact Site Map  Go